Letter to Cepheid cites continued cost of machines, Russia, China cartridge costs of five to six times negotiated price, and more In the discouraging and growing landscape of drug-resistant tuberculosis, physicians, researchers and policy makers have noted, the launch of Cepheid’s GeneXpert MTB/RTF rapid TB diagnostic test has stood alone in both the progress against […]
HIV
The following is a guest post by Emily Bobrow, PhD, of MEASURE Evaluation A combination of integrated service delivery approaches for mothers who are living with […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
The following is a guest post by Jeffrey Duchin, MD, FIDSA The quarantine and travel restrictions announced by the US federal government in response to the […]